Biolife Solutions (BLFS) Interest Expenses (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Interest Expenses of $14.4 million for Q1 2026, up 409.31% year-over-year from $2.8 million in Q1 2025, and up 12088.98% quarter-over-quarter from $118000.0 in Q4 2025.
Biolife Solutions (BLFS) Interest Expenses (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Interest Expenses for 16 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 409.31% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $14.4 million (up 409.31% YoY), while the FY2025 annual figure was $762000.0, down 98.69% from the prior year.
- Interest Expenses improved to $14.4 million in Q1 2026 per BLFS's latest filing, from $118000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $54.7 million in Q1 2024 and bottomed at $118000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $17.5 million across 5 years, with a median of $14.4 million in 2026.
- Annual changes were most pronounced in 2025 — Interest Expenses plunged 94.84% — and 2026, when it soared 409.31%.
- Biolife Solutions' Interest Expenses stood at $356000.0 in 2022, then soared by 49.72% to $533000.0 in 2023, then plunged by 30.21% to $372000.0 in 2024, then slumped by 68.28% to $118000.0 in 2025, then soared by 12088.98% to $14.4 million in 2026.
- Business Quant data shows BLFS's Interest Expenses at $14.4 million in Q1 2026, $118000.0 in Q4 2025, and $15.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.26 Mn |
| Jun 30, 2026 | 19.26 Mn |
| Mar 31, 2026 | 14.38 Mn |
| Mar 31, 2026 | 14.38 Mn |
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 15.59 Mn |
| Sep 30, 2025 | 15.59 Mn |
| Jun 30, 2025 | 16.37 Mn |
| Jun 30, 2025 | 16.37 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 372,000.00 |
| Dec 31, 2024 | 372,000.00 |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 54.70 Mn |
| Mar 31, 2024 | 54.70 Mn |